Apollo Neuroscience, Inc. — Form D
Apollo Neuroscience, Inc. of PITTSBURGH, PA, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-30. The offering totals $2.0M, of which $500K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2024-04-30
- Form: D
- Accession: 0001735427-24-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $500K
- Remaining: $1.5M
- Investors: 1
- Date of first sale: 2024-04-15
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-511993
Issuer
- Name: Apollo Neuroscience, Inc.
- CIK: 0001735427
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 1942 FIFTH AVENUE, PITTSBURGH, PA, 15219
- Phone: (518) 312-0567
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Alan Cannistraro | Director | Pittsburgh, PA |
| Kathryn Fantauzzi | Director | Pittsburgh, PA |
| Gary Johnson | Director | Waltham, MA |
| David Rabin | Director | Pittsburgh, PA |
| Sa'ad Shah | Director | Pittsburgh, PA |
| Alan Cannistraro | Executive Officer | Pittsburgh, PA |
| Kathryn Fantauzzi | Executive Officer | Pittsburgh, PA |
| David Rabin | Executive Officer | Pittsburgh, PA |
| Kathryn Fantauzzi | Promoter | Pittsburgh, PA |
Other filings by this issuer (9)
More